Delsam Pharma's Artificial Eye Ointment (3.5g tube) recalled due to bacterial contamination in unopened tubes. FDA analysis found unsterile product. Consumers should stop using affected batches.
“Delsam Pharma Artificial Eye Ointment Recall: Bacterial Contamination Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/33845-delsam-pharma-artificial-eye-ointment-recall-bacterial-contamination-risk. Based on FDA recall #D-0488-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0488-2023%22&limit=1).
The FDA announced on Feb. 24, 2023, that Global Pharma Healthcare Private Limited voluntarily recalled Delsam Pharma's Artificial Eye Ointment due to non-sterility risks. The agency said unopened tubes were contaminated with bacteria. Owners should contact the distributor for a refund.
FDA analysis found unopened tubes of the ointment to be contaminated with bacteria, posing a risk of infection. The recall is classified as Class I, the most serious type, indicating a reasonable probability that the product will cause serious adverse health consequences or death.
Context
GovInfoNow's records show Global Pharma Healthcare Private Limited has one other recall on record since Jan. 30, 2023. On Jan. 30, 2023, the company recalled eye drops due to bacterial contamination. Other recent recalls of similar products include Dabur Circle K Antibiotic Ointment Recall (June 2, 2026), Thea Pharma Similasan Eye Drops Recall (April 23, 2026), and Blaine Labs Revitaderm Gel Recall (April 8, 2026).
How to tell if you have this one
Check for the 3.5 grams (1/8 oz.) tube labeled with NDC 72570 122 35, batch number H29, and expiration date 11/30/2023. The product was distributed by Delsam Pharma in New York.
Immediately stop using any unopened tubes of the recalled artificial eye ointment as they contain bacteria that can cause infection.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Product was imported by one distributor, Delsam Pharma, LLC, who further distributed the product via internet sales Nationwide in the USA.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 33 days after the firm started it.
1Firm started the recall
2Published in FDA’s Enforcement Report
3FDA classified it Class I
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0488-2023 (February 24, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0488-2023 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.